Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

727 public trials 122 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Active, Not Recruiting

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

NCT04337177

Conditions
Disease Attributes, Ewing Sarcoma, Glioma, +26 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UCSF, Mission Bay - Benioff Children's Hospital San Francisco, California, United States
  • Children's National Research Institute - Children's National Hospital Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

NCT03598244

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +25 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View Trial Details
Active, Not Recruiting

Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

NCT03363373

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The Hospital for Sick Children Toronto, Canada
  • Rigshospitalet Copenhagen, Denmark
View all 20 locations
View Trial Details

Related conditions